Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons P.J.W. Naudé

Publicaties

Administration of a TNF receptor 2 agonist improves neuropathology and cognitive functions in an Alzheimer’s disease model

Activation of TNF Receptor 2 improves synaptic plasticity and enhances amyloid-β clearance in an Alzheimer's disease mouse model with humanized TNF Receptor 2

A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model

Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases

Serum and cerebrospinal fluid neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia

Iron chelators inhibit amyloid-beta-induced production of lipocalin 2 in cultured astrocytes

Gender differences in associations of depressive symptoms and anxiety with inflammatory markers in patients with non-obstructive coronary artery disease

Targeting TNFR2 as a novel therapeutic strategy for Alzheimer's disease

Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target

Anxiety disorders and CRP in a population cohort study with 54326 participants: The LifeLines study

Pers/media

Selective manipulation of specific receptors may pave way for new MS therapies